RNU6-107P

Across TCGA pan-cancer cohorts, RNU6-107P RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated RNU6-107P data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher RNU6-107P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-107P expression acts as an unfavorable survival marker, although some lineages such as LAML and CESC show a favorable association.

ACC, UVM, and CHOL are the cancer types where RNU6-107P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Tertile	All	0.272	0.724	<.001	77	view →
UVM	OS	Tertile	III,IV	0.104	0.813	.001	72	view →
CHOL	DFS	Tertile	II,III,IV	0.099	0.495	.021	36	view →
LAML	DFS	Median	All	0.526	0.267	.012	36	view →
CESC	OS	Tertile	IV	0.701	0.186	.020	24	view →
LUAD	OS	Quartile	All	0.777	0.660	.009	21	view →
COAD	DFS	Tertile	II,III,IV	0.604	0.770	.019	18	view →
BLCA	DFS	Tertile	IV	0.504	0.308	.019	18	view →
THCA	DFS	Tertile	III,IV	0.510	0.804	.009	18	view →
ESCA	OS	Tertile	All	0.382	0.629	.003	14	view →
KICH	OS	Tertile	III,IV	0.162	0.808	.001	9	view →
READ	DFS	Tertile	IV	0.255	0.628	.020	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

RNU6-107P–ACC (DFS)

Open the ACC breakdown →